ALDA Pharmaceuticals Corp.

ALDA Pharmaceuticals Corp.

April 19, 2007 11:24 ET

ALDA Develops Superior Hand Sanitizer

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - April 19, 2007) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("ALDA") has completed the development of a superior hand sanitizer based on its patent-pending T36® infection control technology. Tests indicate that ALDA's T36® Hand Sanitizer is approximately 3,000 times more powerful than common alcohol-based hand sanitizers. ALDA has developed this new T36® Hand Sanitizer to meet a world-wide demand of $2.5 Billion from consumers, commercial establishments and medical facilities for hand hygiene products.

About ALDA

ALDA's patent-pending T36® formulation contains active ingredients in very low concentrations that act in concert to disrupt the physical structure of all infectious organisms rather than interfering with their metabolic pathways. The competitive advantage of this approach is the ability to kill all infectious organisms while preventing microbial resistance, side effects or toxicity.

Terrance G. Owen, Ph.D., MBA, President, CEO and Director

ALDA Pharmaceuticals Corp.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information